Population-based self-sampling under primary care conditions - a possible approach for cervical cancer screening in Indonesia (IndoCerCa study).

IF 3.4 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Supriyatiningsih Wenang, Dianita Sugiyo, Sutantri Sutantri, Lidia Febrianti, Wiwik Kusumawati, Ova Emilia, Muhammad Ary Zucha, Ardhanu Kusumanto, Detty Siti Nurdiati, Mohamad Saifudin Hakim, Faizah Dwi Tirtasari, Boedi Andriani Ontowiryo, Pia Wilkening, Peter Hillemanns, Jörg Haier
{"title":"Population-based self-sampling under primary care conditions - a possible approach for cervical cancer screening in Indonesia (IndoCerCa study).","authors":"Supriyatiningsih Wenang, Dianita Sugiyo, Sutantri Sutantri, Lidia Febrianti, Wiwik Kusumawati, Ova Emilia, Muhammad Ary Zucha, Ardhanu Kusumanto, Detty Siti Nurdiati, Mohamad Saifudin Hakim, Faizah Dwi Tirtasari, Boedi Andriani Ontowiryo, Pia Wilkening, Peter Hillemanns, Jörg Haier","doi":"10.1186/s12978-026-02350-9","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>In low- and middle-income countries (LMICs), cervical cancer is a major burden. Screening is mainly based on visual inspection lacking sufficient sensitivity and specificity. For roll-out of colposcopy-based early detection sufficient qualified staff is not available. Several self-sampling device products have been proposed as alternative, but their usability in primary care needs to be proven. Implementation of an HPV-based self-sampling approach in a population-based setting in Indonesia was evaluated.</p><p><strong>Methods: </strong>Four self-sampling devices (2 urine, 2 swab) were applied in a primary care setting covering an entire district in Indonesia with Kulon Progo as pilot region. Cluster randomization was used for comparison of rural and urban areas. HPV-testing was done using standardized and validated PCR-techniques. HPV-positive women and a randomly selected HPV-negative control group underwent colposcopy, PAP smears and biopsies for cervical intraepithelial neoplasia (CIN) validation.</p><p><strong>Results: </strong>In 21 primary care units 2056 women (30-55 y) were recruited. Three devices achieved sufficient technical validation (92.1 - 99.7% DNA detection rate). Participant's test acceptance was 99.1%. HPV-prevalence was 2.6% (urine 2.4%, swab 2.8%). In 29.4% of HPV-positive women high-risk HPV-16/18 were detected. Colposcopy and morphological examination were refused by 3.0% of HPV-positive women and were technically invalid in 5.0%. Pathology revealed Negative for Intraepithelial Lesion or Malignancy (NILM) in 55.8%, CIN I in 25.0% and CIN II + in 3.8%. In the control group CIN I was found in 2.0%. This resulted in a sensitivity of 27.4% for all CIN and 100.0% for CIN II + , with specificities of 98.5% and 97.7%, respectively. The negative predictive values (NPV) were 97.9% and 100.0%, and positive predictive values (PPV) were 34.1% and 4.5%. Regression analysis confirmed high negative predictive impact of HPV-negativity in women > 40 years.</p><p><strong>Conclusions: </strong>Under primary care setting self-sampling-based HPV-testing is accepted. Urine- and swab-based techniques can be applied if the test systems provide technically valid DNA-detection rates. The prevalence was very low and requires further comparison within Indonesia. High NPV of this approach supports its applicability as screening in LMICs. For high-risk lesions PPV is still low suggesting a combination with additional test that are mainly independent from the availability of qualified staff.</p>","PeriodicalId":20899,"journal":{"name":"Reproductive Health","volume":" ","pages":""},"PeriodicalIF":3.4000,"publicationDate":"2026-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reproductive Health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12978-026-02350-9","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: In low- and middle-income countries (LMICs), cervical cancer is a major burden. Screening is mainly based on visual inspection lacking sufficient sensitivity and specificity. For roll-out of colposcopy-based early detection sufficient qualified staff is not available. Several self-sampling device products have been proposed as alternative, but their usability in primary care needs to be proven. Implementation of an HPV-based self-sampling approach in a population-based setting in Indonesia was evaluated.

Methods: Four self-sampling devices (2 urine, 2 swab) were applied in a primary care setting covering an entire district in Indonesia with Kulon Progo as pilot region. Cluster randomization was used for comparison of rural and urban areas. HPV-testing was done using standardized and validated PCR-techniques. HPV-positive women and a randomly selected HPV-negative control group underwent colposcopy, PAP smears and biopsies for cervical intraepithelial neoplasia (CIN) validation.

Results: In 21 primary care units 2056 women (30-55 y) were recruited. Three devices achieved sufficient technical validation (92.1 - 99.7% DNA detection rate). Participant's test acceptance was 99.1%. HPV-prevalence was 2.6% (urine 2.4%, swab 2.8%). In 29.4% of HPV-positive women high-risk HPV-16/18 were detected. Colposcopy and morphological examination were refused by 3.0% of HPV-positive women and were technically invalid in 5.0%. Pathology revealed Negative for Intraepithelial Lesion or Malignancy (NILM) in 55.8%, CIN I in 25.0% and CIN II + in 3.8%. In the control group CIN I was found in 2.0%. This resulted in a sensitivity of 27.4% for all CIN and 100.0% for CIN II + , with specificities of 98.5% and 97.7%, respectively. The negative predictive values (NPV) were 97.9% and 100.0%, and positive predictive values (PPV) were 34.1% and 4.5%. Regression analysis confirmed high negative predictive impact of HPV-negativity in women > 40 years.

Conclusions: Under primary care setting self-sampling-based HPV-testing is accepted. Urine- and swab-based techniques can be applied if the test systems provide technically valid DNA-detection rates. The prevalence was very low and requires further comparison within Indonesia. High NPV of this approach supports its applicability as screening in LMICs. For high-risk lesions PPV is still low suggesting a combination with additional test that are mainly independent from the availability of qualified staff.

在初级保健条件下以人群为基础的自我抽样——印度尼西亚宫颈癌筛查的一种可能方法(IndoCerCa研究)。
在低收入和中等收入国家(LMICs),子宫颈癌是一个主要负担。筛查以目视检查为主,缺乏足够的敏感性和特异性。对于推出基于阴道镜的早期检测,没有足够的合格工作人员。一些自采样设备产品已被提议作为替代方案,但它们在初级保健中的可用性需要得到证实。评估了在印度尼西亚以人口为基础的环境中实施的基于人乳头状病毒的自我抽样方法。方法:以Kulon Progo为试点地区,在印度尼西亚一个覆盖整个地区的初级保健机构中应用了4种自采样装置(2种尿液,2种棉签)。采用聚类随机法对农村和城市地区进行比较。hpv检测采用标准化和经过验证的pcr技术进行。hpv阳性妇女和随机选择的hpv阴性对照组接受阴道镜检查、PAP涂片检查和宫颈上皮内瘤变活检(CIN)验证。结果:在21个初级保健单位招募了2056名妇女(30-55岁)。三个装置达到了充分的技术验证(DNA检出率92.1 ~ 99.7%)。参与者的测试接受度为99.1%。hpv患病率为2.6%(尿液2.4%,拭子2.8%)。在29.4%的hpv阳性妇女中检测到高危HPV-16/18。3.0%的hpv阳性妇女拒绝阴道镜检查和形态学检查,5.0%在技术上无效。病理显示上皮内病变或恶性(NILM)阴性占55.8%,CIN为25.0%,CIN为3.8%。对照组CIN发生率为2.0%。这导致所有CIN的敏感性为27.4%,CIN II +的敏感性为100.0%,特异性分别为98.5%和97.7%。阴性预测值(NPV)分别为97.9%和100.0%,阳性预测值(PPV)分别为34.1%和4.5%。回归分析证实,hpv阴性对40岁以下女性的预测影响较高。结论:在初级保健环境下,基于自采样的hpv检测是可以接受的。如果测试系统能够提供技术上有效的dna检测率,则可以应用基于尿液和拭子的技术。流行率很低,需要在印度尼西亚进行进一步比较。该方法的高净现值支持其在中低收入国家筛查中的适用性。对于高风险病变,PPV仍然很低,建议与主要独立于合格工作人员的额外检测相结合。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Reproductive Health
Reproductive Health PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-
CiteScore
6.00
自引率
5.90%
发文量
220
审稿时长
>12 weeks
期刊介绍: Reproductive Health focuses on all aspects of human reproduction. The journal includes sections dedicated to adolescent health, female fertility and midwifery and all content is open access. Reproductive health is defined as a state of physical, mental, and social well-being in all matters relating to the reproductive system, at all stages of life. Good reproductive health implies that people are able to have a satisfying and safe sex life, the capability to reproduce and the freedom to decide if, when, and how often to do so. Men and women should be informed about and have access to safe, effective, affordable, and acceptable methods of family planning of their choice, and the right to appropriate health-care services that enable women to safely go through pregnancy and childbirth.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书